All In Biotech

Drug Trial Radar · NCT04158336

A Study of Azenosertib (ZN-c3) in Participants With Solid Tumors

A Phase 1 Study of ZN-c3 as a Single Agent in Subjects With Solid Tumors

Last checked: Nov 19, 2026Latest source record: Mar 18, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingRandomized with 274 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

274

Actual

Start

Nov 1, 2019

Primary completion

May 6, 2025

Study completion May 6, 2025

Sponsor

Sponsor type
Industry
First posted
Nov 8, 2019

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is a Phase 1 open-label, multicenter study of ZN-c3 (also known as Azenosertib) monotherapy which consists of Dose Escalation, a Food Effect Cohort, and Dose Expansion.

Conditions

  • Solid Tumor

Interventions

  • AzenosertibDrug

    Azenosertib (ZN-c3) is a study drug

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Dose EscalationTime frame: Through completion, average of 1 year
  2. Food Effect CohortTime frame: Through completion, approx 6 months
  3. Food Effect CohortTime frame: Through completion, approximately 6 months
  4. Food Effect CohortTime frame: Through completion approximately 6 month
  5. Food Effect CohortTime frame: Through completion, approximately 6 mth
  6. Dose ExpansionTime frame: Through completion, approximately 43 month

Locations

8 sites in 1 country. Site status is shown where the registry gives one.

  • Site 0102

    Tucson, Arizona

  • Site 0167

    Newport Beach, California

  • Site 0171

    Chicago, Illinois

  • Site 0101

    Detroit, Michigan

  • Site 0173

    New York, New York

  • Site 0179

    Pittsburgh, Pennsylvania

  • Site 0103

    Houston, Texas

  • Site 0100

    San Antonio, Texas

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.